----item----
version: 1
id: {1CD1DB99-CB8F-4E35-B25E-1BF23945115A}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/1995/08/14/Prototype for nonfasting diabetes screening ready soon
parent: {ACFE9AD7-B783-471B-A6C5-F5D7703FA937}
name: Prototype for nonfasting diabetes screening ready soon
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: d0c8e4da-977d-4e74-80c6-27dbf5542352

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 285

<p>SpectRx plans to complete a prototype non-invasive diabetes screening instrument next January and production is planned to commence later in 1996. The privately-held development-stage company, based in Georgia, US, is developing the instrument for Boehringer Mannheim (Germany).</p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 55

Prototype for non-fasting diabetes screening ready soon
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1453

<p>SpectRx plans to complete a prototype non-invasive diabetes screening instrument next January and production is planned to commence later in 1996. The privately-held development-stage company, based in Georgia, US, is developing the instrument for Boehringer Mannheim (Germany).</p><p>The instrument is designed to replace the fasting plasma glucose test. It offers the advantages of diagnosis, within 20 seconds, without fasting, drawing blood or generating hazardous waste. The system will use low-level blue light reflection measurement in a patient's eye to give a yes/no result. The monitoring system that SpectRx is developing with <strong>[C#198600626:Teijin]</strong> for the Asian market uses multi-colour light (see Clinica No 666, p 8).</p><p>To complement SpectRx' diabetes screening technology, the company has struck a co-operation deal with TheraTech for a painless, bloodless, glucose monitoring product and <strong>[C#199901331:transdermal]</strong> delivery system. The new glucose insta-test will require two steps, SpectRx says: placing a patch sensor on the skin and then overlaying it with a hand-held monitor for almost instant results. The monitor creates a painless micropore in the skin, and a pumping system draws interstitial fluid (ISF) into the disposable sensor patch collection device. ISF is the extracellular fluid through which metabolites, including glucose, pass when travelling between capillaries and cells.</p>
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 155

{F5161CC2-772F-472E-A21C-BF196343462E}|{58DF7E50-F43F-4AA9-886E-A49EEC7FF831}|{72D49F7F-DA69-4EE0-ACAA-8D50362AD510}|{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 54

Prototype for nonfasting diabetes screening ready soon
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

19950814T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

19950814T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

19950814T000000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT053879
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 55

Prototype for non-fasting diabetes screening ready soon
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 19

199901331,198600626
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

255688
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T184638Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

d0c8e4da-977d-4e74-80c6-27dbf5542352
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T184638Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
